Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin

  1. Alireza R. Rezaie* and
  2. Likui Yang
  1. Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, MO 63104
  1. Communicated by Charles T. Esmon, Oklahoma Medical Research Foundation, Oklahoma City, OK, August 20, 2003 (received for review June 5, 2003)

Abstract

Exosite 1 of thrombin consists of a cluster of basic residues (Arg-35, Lys-36, Arg-67, Lys-70, Arg-73, Arg-75, and Arg-77 in chymotrypsinogen numbering) that play key roles in the function of thrombin. Structural data suggest that the side chain of Arg-35 projects toward the active site pocket of thrombin, but all other residues are poised to interact with thrombomodulin (TM). To study the role of these residues in TM-mediated protein C (PC) activation by thrombin, a charge reversal mutagenesis approach was used to replace these residues with a Glu in separate constructs. The catalytic properties of the mutants toward PC were analyzed in both the absence and presence of TM and Ca2+. It was discovered that, with the exception of the Arg-67 and Lys-70 mutants, all other mutants activated PC with similar maximum rate constants in the presence of a saturating concentration of TM and Ca2+, although their affinity for interaction with TM was markedly impaired. The catalytic properties of the Arg-35 mutant were changed so that PC activation by the mutant no longer required Ca2+ in the presence of TM, but, instead, it was accelerated by EDTA. Moreover, the activity of this mutant toward PC was improved ≈25-fold independent of TM. These results suggest that Arg-35 is responsible for the Ca2+ dependence of PC activation by the thrombin–TM complex and that a function for TM in the activation complex is the allosteric alleviation of the inhibitory interaction of Arg-35 with the substrate.

Footnotes

  • * To whom correspondence should be addressed. E-mail: rezaiear{at}slu.edu.

  • Abbreviations: PC, protein C; APC, activated PC; TM, thrombomodulin; EGF, epidermal growth factor; TM456, TM fragment containing the EGF-like domains 4, 5, and 6; Gla, γ-carboxyglutamic residue; GD-PC, Gla-domainless PC from which the amino-terminal residues 1–45 have been removed by recombinant DNA methods; AT, antithrombin.

« Previous | Next Article »Table of Contents